OpenURL Connection Search

Select item for more details and to access through your institution.

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008.
Published in:
PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101510
By:
- Pfaller, Michael A.;
- Andes, David R.;
- Diekema, Daniel J.;
- Horn, David L.;
- Reboli, Annette C.;
- Rotstein, Coleman;
- Franks, Billy;
- Azie, Nkechi E.
Publication type:
Article
Cardiovascular effect of almotriptan in treated hypertensive patients*.
Published in:
Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 3, p. 169, doi. 10.1067/mcp.2002.121372
By:
- Fleishaker, Joseph C.;
- McEnroe, Janet D.;
- Azie, Nkechi E.;
- Francom, Steven F.;
- Carel, Barbara J.
Publication type:
Article
Lack of effect of reboxetine on cardiac repolarization.
Published in:
Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 3, p. 261, doi. 10.1067/mcp.2001.117705
By:
- Fleishaker, Joseph C.;
- Francom, Steven F.;
- Herman, Beth D.;
- Knuth, Dean W.;
- Azie, Nkechi E.
Publication type:
Article
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers*.
Published in:
Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 5, p. 498, doi. 10.1067/mcp.2000.106292
By:
- Fleishaker, Joseph C.;
- Sisson, Theresa A.;
- Carel, Barbara J.;
- Azie, Nkechi E.
Publication type:
Article
The interaction of diltiazem with lovastatin and pravastatin*.
Published in:
Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 369, doi. 10.1016/S0009-9236(98)90067-4
By:
- Azie, Nkechi E.;
- Brater, D. Craig;
- Becker, Paula A.;
- Jones, David R.;
- Hall, Stephen D.
Publication type:
Article
Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis.
Published in:
Clinical Infectious Diseases, 2022, v. 74, n. 12, p. 2129, doi. 10.1093/cid/ciab841
By:
- Nyirjesy, Paul;
- Schwebke, Jane R;
- Angulo, David A;
- Harriott, Itzel A;
- Azie, Nkechi E;
- Sobel, Jack D
Publication type:
Article
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).
Published in:
Clinical Infectious Diseases, 2022, v. 74, n. 11, p. 1979, doi. 10.1093/cid/ciab750
By:
- Schwebke, Jane R;
- Sobel, Ryan;
- Gersten, Janet K;
- Sussman, Steven A;
- Lederman, Samuel N;
- Jacobs, Mark A;
- Chappell, B Todd;
- Weinstein, David L;
- Moffett, Alfred H;
- Azie, Nkechi E;
- Angulo, David A;
- Harriott, Itzel A;
- Borroto-Esoda, Katyna;
- Ghannoum, Mahmoud A;
- Nyirjesy, Paul;
- Sobel, Jack D
Publication type:
Article
Effect of MAO-A inhibitors on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
Published in:
British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 437, doi. 10.1046/j.1365-2125.2001.01367.x
By:
- Fleishaker, Joseph C.;
- Ryan, Kristi K.;
- Jansat, Josep M.;
- Carel, Barbara J.;
- Bell, David J.A.;
- Burke, Moira T.;
- Azie, Nkechi E.
Publication type:
Article
Intravenous diltizem and CYP3A-mediated metabolism.
Published in:
British Journal of Clinical Pharmacology, 2000, v. 50, n. 3, p. 273, doi. 10.1046/j.1365-2125.2000.00249.x
By:
- Masica, Andrew L.;
- Azie, Nkechi E.;
- Brater, D. Craig;
- Hall, Stephen D.;
- Jones, David R.
Publication type:
Article
Single Oral Dose Safety, Tolerability, and Pharmacokinetics of PNU-96391 in Healthy Volunteers.
Published in:
Journal of Clinical Pharmacology, 2004, v. 44, n. 3, p. 276
By:
- Carlos A. Rodríguez;
- Nkechi E. Azie;
- Gregory Adams;
- Kirsteen Donaldson;
- Steven F. Francom;
- Brian A. Staton;
- Paul A. Bombardt
Publication type:
Article
Interaction between Ketoconazole and Almotriptan in Healthy Volunteers.
Published in:
Journal of Clinical Pharmacology, 2003, v. 43, n. 4, p. 423
By:
- Joseph C. Fleishaker;
- Beth D. Herman;
- Barbara J. Carel;
- Nkechi E. Azie
Publication type:
Article
Evaluation of the Potential Pharmacokinetic Interaction between Almotriptan and Fluoxetine in Healthy Volunteers.
Published in:
Journal of Clinical Pharmacology, 2001, v. 41, n. 2, p. 217, doi. 10.1177/009127000104100214
By:
- Fleishaker, Joseph C.;
- Ryan, Kristi K.;
- Carel, Barbara J.;
- Azie, Nkechi E.
Publication type:
Article
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Published in:
2004
By:
- Azie NE;
- Adams G;
- Darpo B;
- Francom SF;
- Polasek EC;
- Wisser JM;
- Fleishaker JC;
- Azie, Nkechi E;
- Adams, Gregory;
- Darpo, Borje;
- Francom, Steven F;
- Polasek, Emery C;
- Wisser, Joy M;
- Fleishaker, Joseph C
Publication type:
journal article
Comparing Methods of Measurement for Detecting Drug-Induced Changes in the QT Interval: Implications for Thoroughly Conducted ECG Studies.
Published in:
Annals of Noninvasive Electrocardiology, 2004, v. 9, n. 2, p. 166, doi. 10.1111/j.1542-474X.2004.92542.x
By:
- Azie, Nkechi E.;
- Adams, Gregory;
- Darpo, Borje;
- Francom, Steven F.;
- Polasek, Emery C.;
- Wisser, Joy M.;
- Fleishaker, Joseph C.
Publication type:
Article
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections.
Published in:
Journal of Fungi, 2022, v. 8, n. 11, p. 1121, doi. 10.3390/jof8111121
By:
- Angulo, David A.;
- Alexander, Barbara;
- Rautemaa-Richardson, Riina;
- Alastruey-Izquierdo, Ana;
- Hoenigl, Martin;
- Ibrahim, Ashraf S.;
- Ghannoum, Mahmoud A.;
- King, Thomas R.;
- Azie, Nkechi E.;
- Walsh, Thomas J.
Publication type:
Article
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry.
Published in:
Mycoses, 2014, v. 57, n. 11, p. 652, doi. 10.1111/myc.12212
By:
- Horn, David L.;
- Freifeld, Alison G.;
- Schuster, Mindy G.;
- Azie, Nkechi E.;
- Franks, Billy;
- Kauffman, Carol A.
Publication type:
Article
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306.
Published in:
Journal of Women's Health (15409996), 2023, v. 32, n. 2, p. 178, doi. 10.1089/jwh.2022.0132
By:
- Goje, Oluwatosin;
- Sobel, Ryan;
- Nyirjesy, Paul;
- Goldstein, Steven R.;
- Spitzer, Mark;
- Faught, Brooke;
- Larson, Shelagh;
- King, Thomas;
- Azie, Nkechi E.;
- Angulo, David;
- Sobel, Jack D.
Publication type:
Article

Found: 17

Epidemiology and Outcomes of Invasive Candidiasis Due to Non<i>-albicans</i> Species of <i>Candida</i> in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008.

Cardiovascular effect of almotriptan in treated hypertensive patients<sup>*</sup>.

Lack of effect of reboxetine on cardiac repolarization.

Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers<sup>*</sup>.

The interaction of diltiazem with lovastatin and pravastatin<sup>*</sup>.

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis.

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).

Effect of MAO-A inhibitors on the pharmacokinetics of almotriptan, an antimigraine agent in humans.

Intravenous diltizem and CYP3A-mediated metabolism.

Single Oral Dose Safety, Tolerability, and Pharmacokinetics of PNU-96391 in Healthy Volunteers.

Interaction between Ketoconazole and Almotriptan in Healthy Volunteers.

Evaluation of the Potential Pharmacokinetic Interaction between Almotriptan and Fluoxetine in Healthy Volunteers.

Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

Comparing Methods of Measurement for Detecting Drug-Induced Changes in the QT Interval: Implications for Thoroughly Conducted ECG Studies.

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections.

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance<sup>®</sup> registry.

Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306.